Valeant Pharmaceuticals International, Inc. (VRX)
-NYSE 108.16 
3.83(3.67%) Oct 1, 4:02PM EDT|After Hours
:
108.16 0.00 (0.00%) Oct 1, 4:04PM EDT
| Prev Close: | 104.33 |
|---|
| Open: | 104.04 |
|---|
| Bid: | 106.35 x 100 |
|---|
| Ask: | 111.21 x 100 |
|---|
| 1y Target Est: | 52.38 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 104.04 - 108.17 |
|---|
| 52wk Range: | 52.50 - 108.17 |
|---|
| Volume: | 1,171,540 |
|---|
| Avg Vol (3m): | 1,180,920 |
|---|
| Market Cap: | 36.07B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Stocks Open Quietly Higher; Merck, Netflix, Valeant Risingat Investor's Business Daily(Tue, Oct 1)
- With Leadership Established, Breakouts Now Could Lack Punchat Investor's Business Daily(Mon, Sep 30)
- Data on Novartis' LucentisZacks(Mon, Sep 30)
- IBD 50 Up For Week, But Not By Muchat Investor's Business Daily(Fri, Sep 27)
- Jazz Pharmaceuticals Stares At Generic Threat, Thrivesat Investor's Business Daily(Fri, Sep 27)
- Is An Acquisition Of Solta Medical Imminent?at Seeking Alpha(Wed, Sep 25)
- 5 Health Care Stocks Pushing Sector Growthat TheStreet(Tue, Sep 24)
- Interesting VRX Put And Call For November 16that Forbes(Mon, Sep 23)
- Valeant Pharmaceuticals Buys Its Way To The Topat Investor's Business Daily(Thu, Sep 19)
- Insiders Were Right: VRX Makes New 52-Week Highat Forbes(Thu, Sep 19)
- Jim Cramer: Buy Verizon, Wynn Resorts, and 3 More Stock Picksat Wall St. Cheat Sheet(Thu, Sep 19)
- Lightning Round: Merck, Applied Materials & Moreat CNBC(Wed, Sep 18)
- [video] Lightning Roundat CNBC(Wed, Sep 18)
- Insiders at MVC Capital and Valeant Buy Shares, and WebMD Sees a Major Saleat Minyanville(Wed, Sep 18)
- Valeant initiated with a Conviction Buy at Goldmanat theflyonthewall.com(Tue, Sep 17)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 8.62 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-10)
: | N/A |
|---|
| Quarterly EPS Est
(Sep-10)
: | N/A |
|---|
| Mean Recommendation*: | 3.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products and medical devices in the areas of neurology, dermatology, and branded generics.
View More